Navigation Links
'Heart' of Herschel to be presented to media
Date:9/4/2007

By the end of 2007, the assembly of the ESA's Herschel far-infrared space observatory - the latest mission to study the formation and evolution of stars and galaxies - will be completed.

ESA and Astrium are jointly inviting the media to a press conference in Friedrichshafen, Germany, on 19 September 2007, to hear about this revolutionary spacecraft, its scientific objectives, and to view the very heart of its hardware.

The Herschel mission, equipped with the largest telescope ever launched in space (3.5 m diameter), will give astronomers their best capability yet to explore the universe at far-infrared and sub-millimetre wavelengths. By measuring the light at these wavelengths, scientists see the 'cold' universe. Herschel will give them an unprecedented view, allowing them to see deep into star forming regions, galactic centres and planetary systems.

In order to achieve its objectives and to be able to detect the faint radiation coming from the coolest objects in the cosmos, otherwise 'invisible', Herschel's detectors must operate at very low and stable temperatures. The spacecraft is equipped so as to cool them close to absolute zero (-273.15 C), ranging from -271 C to only a few tenths of a degree above absolute zero. To have achieved this particular feature alone is a remarkable accomplishment for European industry and science.

The final integration of the various components of the Herschel spacecraft - payload module, cryostat, service module, telescope and solar arrays - will be completed in the next few months. This phase will be followed by a series of tests to get the spacecraft ready for launch at the end of July 2008. Herschel will be launched into space on an Ariane 5 ECA rocket. The launch is shared with Planck, ESA's mission to study relic radiation from the Big Bang.


'/>"/>

Contact: ESA Media Relations Office
media@esa.int
33-015-369-7299
European Space Agency
Source:Eurekalert

Page: 1

Related biology news :

1. HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs
2. UCSD team discovers specialized, rare heart stem cells in newborns
3. Implanted Devices Detect High-Risk Heart Failure Patients
4. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
5. Special Imaging Study Shows Failing Hearts Are Energy Starved
6. Stem Cell Research Shows Potential for Replacing Tissue Damaged in Heart Attacks
7. Single stem cells from bone heal a broken heart
8. Heart repair gets new muscle
9. Python a hearty eater
10. Columbia study shows widely used artery clearing device does not help patients during heart attack
11. Researchers reveal secret of key protein in brain and heart function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... June 22, 2016   Acuant , ... verification solutions, has partnered with RightCrowd ® ... for Visitor Management, Self-Service Kiosks and Continuous ... that add functional enhancements to existing physical ... and venues with an automated ID verification ...
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory ... technical consulting, provides a free webinar on Performing Quality Investigations: Getting ... at 12pm CT at no charge. , Incomplete investigations are still a major ...
(Date:6/22/2016)... Research and Markets has announced the addition of the ... The global biomarkers market has ... The market is expected to grow at a five-year compound annual ... $50.6 billion in 2015 to $96.6 billion in 2020. ... to 2020) are discussed. As well, new products approved in 2013 ...
Breaking Biology Technology: